A review on novel methodologies for drug nanoparticle preparation: Microfluidic approach
Introduction
Novel drug delivery methodologies have started to emerge over the conventional dosage forms aiming to enhance therapeutic efficiency and patient compliance. The novel drug delivery approaches seek to reduce the cost involved in new drug development, drug side-effects and to improve the affinity to controlled release (Kumar et al., 2012). The novel drug delivery methods include the controlled release, sustained release, and targeted release dosage. To date, more than 80 applications of nanocrystals have been submitted to the US Food and Drug Administration (USFDA). These therapeutics can be delivered through various routes of administration – 63% of the applications are for the oral route of drug administration (Chen et al., 2017). Drug delivery through pulmonary and nasal tract has also gained significance with ongoing research and development. To ease the drug administration, patient compliance and to provide the flexibility of design of dosage; oral route of delivery is preferred the most in comparison to other methods (Mali et al., 2015). About 40% available drugs belong to the Biopharmaceutical Classification System (BCS) class II drugs which have poor aqueous solubility and low bioavailability. Hence, there is a constant need for the development in drug delivery methods which allows maximum therapeutic effectiveness. This can be achieved by drug encapsulation. Encapsulation of drug in the nano-sized polymeric particles can give minimal drug side effect, controlled drug release, and enhanced bioavailability (Langer, 1998).
In recent years, micro/nano materials have attracted the attention of many researchers towards their biomedical applications (Heath et al., 2016; Mitragotri et al., 2015; Tibbitt et al., 2016). Newly developed carriers hold great promise in accomplishing increased bioavailability, controlled drug release, and enhanced viability that can eventually achieve desired therapeutic response. Among these carriers, micro (Leong and Wang, 2015; Skorb and Möhwald, 2014) and nano (Gref et al., 1995; Wang et al., 2012) structures have gained considerable research interest because of their physical (size, structures, porosity, and mechanical strength) and chemical (compositions, reactivity, biocompatibility, and biodegradability) properties, and flexibility in integrating different functions. In particular, the nano drug delivery system provides a defensive impact against the degradation of drug, controlled therapeutic release profile, and the chance of accurately targeting the drug molecules to the specific site (Blanco et al., 2015). These advantages of nano drug delivery system enable the utilization of lower drug dose with minimal side effects as compared to bare drug molecules (Tang et al., 2016).
The two main methods for producing drug nanoparticles are top-down and bottom-up methods. In the top-down approach, large crystalline drug particles are converted to nanosized drug particles using mechanical force. These methods are easy for industrial scale-up with fine particle producing capacity and reproducibility. However, the major disadvantages of top-down approach are high equipment cost, uncontrolled particle growth, requirement of an intensive amount of energy, and a chance of product contamination (Gera et al., 2017). On the other hand, bottom-up approaches reduce drug particle size using the crystallization process. By using this approach usually, amorphous particles are produced thus enhancing solubility and bioavailability of the drug. However, amorphous form tends to re-agglomerate and has stability issues (Soliman et al., 2017). Bottom-up approaches are simple, rapid, energy efficient, and cost-effective (Azad et al., 2014). These techniques are more efficient at the laboratory scale, and smaller particle size with narrow particle size distribution can be achieved using these methods. The single step bottom-up approaches also have some disadvantages such as low yield, batch-to-batch variation, scaling up, and uncontrolled growth of particles. Nowadays, to produce drug nanoparticles with desirable properties, various combination approaches have been widely studied. In general, a combination technique involves a preprocessing step with a subsequent high energy step. Each approach has its advantages and disadvantages with a common aim of producing particles with good physicochemical stability, narrow particle size distribution, controlled particle growth, high purity, reproducible size, and desired morphology (Möschwitzer, 2010).
The emergence of microreactor technology has brought many opportunities for preparing drug nanoparticles with controlled properties. Microfluidics is defined as the science and technology which deals with fluid flow within micron size channels (Whitesides, 2006). In this micron range, the fluid behavior is majorly affected by fluid viscosity rather than inertia, and high surface area to volume ratio provides quick heat and mass transfer (Zhang et al., 2016). Owing to miniaturization of fluidic environment and continuous mode of operation, microreactor technology offers improved controllability, reduced batch-to-batch variation, narrow particle size distribution, reduced reagent consumption, and high reproducibility. In comparison with conventional processes, these intrinsic properties make microreactor technology attractive for producing drug micro/nano particles. Also, microfluidics has unique characteristics of using pico-to-nanoliter of reagent, millisecond mixing time, real-time monitoring/imaging, and direct scale-up. These characteristics offer microreactor technology as a cost-effective and high throughput technology (Ran et al., 2017). In the last few years, studies on the combination of microfluidic with precipitation and emulsification for drug encapsulation have been reported. Bramosanti et al. (2017) encapsulated Ribavirin in PLGA nanoparticles using microfluidic assisted nanoprecipitation technique. Hydrodynamic flow focusing geometry was utilized to prepare sustained release formulation of Ribavirin. The study demonstrated the significance of microfluidics for enhancing drug encapsulation and to tightly control process parameters (Bramosanti et al., 2017). de Solorzano et al. (2016) investigated microchannel emulsification by encapsulating cyclosporine into PLGA nanoparticles.
The current review revisits three methodologies, viz., (spray drying, high pressure homogenization, and ultrasonication) popularly investigated for drug nanonization and encapsulation in past few years. The advantages and limitations of the aforesaid techniques are discussed along with state-of-the-art in these technologies. The existing challenges of these techniques and their solution through microfluidics are highlighted. The advancement made in the field of drug nanonization and encapsulation through microfluidic technology was reported. Furthermore, the future scope of combining droplet microfluidic emulsification and ultrasonication for drug nanonization and encapsulation was discussed.
Section snippets
Spray drying
Among various techniques utilized for drug nanoparticles preparation, spray drying is widely accepted as it is a simple, fast, reproducible and scalable technology. Spray drying is a continuous technique which consists of an atomizer and a hot drying gas stream to convert a liquid feed into powdered product. The liquid feed comprises of drug particles suspended in the polymeric melt which are dispersed through an atomizer into fine size droplets. Liquid feed can be suspension, emulsion,
Microreactor
In the past few years, microfluidic technology has grown rapidly with extensive applications in preparing nanoparticles, and to carry out various chemical reactions. Microreactor is a device where the reaction takes place in channels with an inner diameter less than 1 mm. The smaller channel dimensions enhance the surface area to volume ratio resulting in higher heat and mass transfer. When compared with conventional batch reactors, this technology offers precise control of process variables
Conclusions
Over the years, various techniques have been widely studied to prepare drug nanoparticles. In this review, we have presented probably the most generally studied methodologies along with a recently emerging technology mocrofluidics. From couple of years, spray drying, high pressure homogenization, and ultrasound have been explored by numerous researchers to encapsulate drug in micro/nano particles for achieving desired therapeutic effectiveness. Using the mentioned techniques, there are still
Declaration of interest
We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.
References (140)
- et al.
Design and characterization of loratadine nanosuspension prepared by ultrasonic-assisted precipitation
Eur. J. Pharm. Sci.
(2018) - et al.
Reconstitutable spray dried ultra-fine dispersion as a robust platform for effective oral delivery of an antihyperlipidemic drug
Int. J. Pharm.
(2017) - et al.
Microfluidic-assisted nanoprecipitation of antiviral-loaded polymeric nanoparticles
Colloids Surf. A Physicochem. Eng. Asp.
(2017) - et al.
Continuous-flow production of polymeric micelles in microreactors: experimental and computational analysis
J. Colloid Interface Sci.
(2011) - et al.
Incorporation of functionalized carbon nanotubes into hydrophobic drug crystals for enhancing aqueous dissolution
Colloids Surf. B Biointerfaces
(2019) - et al.
Production of dry-state ketoprofen-encapsulated PMMA NPs by coupling micromixer-assisted nanoprecipitation and spray drying
Int. J. Pharm.
(2019) - et al.
The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres
Adv. Drug Deliv. Rev.
(1995) - et al.
Concomitant delivery of paclitaxel and NuBCP-9 peptide for synergistic enhancement of cancer therapy
Nanomed. Nanotechnol. Biol. Med.
(2018) - et al.
Ultrasound assisted synthesis of performic acid in a continuous flow microstructured reactor
Ultrason. Sonochem.
(2017) - et al.
Development of porous particles using dextran as an excipient for enhanced deep lung delivery of rifampicin
Int. J. Pharm.
(2019)
Paclitaxel and curcumin co-bound albumin nanoparticles having antitumor potential to pancreatic cancer
Asian J. Pharm. Sci.
Paclitaxel-loaded hyaluronan solid nanoemulsions for enhanced treatment efficacy in ovarian cancer
Int. J. Nanomed.
Lab-on-a-chip synthesis of inorganic nanomaterials and quantum dots for biomedical applications
Adv. Drug Deliv. Rev.
Cell-laden polymeric microspheres for biomedical applications
Trends Biotechnol.
Dissolution and physicochemical stability enhancement of artemisinin and mefloquine co-formulation via nano-confinement with mesoporous SBA-15
Colloids Surf. B Biointerfaces
Development of controlled-release cisplatin dry powders for inhalation against lung cancers
Int. J. Pharm.
Spatially-controlled protein crystallization in microfluidic chambers
J. Cryst. Growth
Using microfluidic platforms to develop CNS-targeted polymeric nanoparticles for HIV therapy
Eur. J. Pharm. Biopharm.
Effects of process variables on the powder yield of spray-dried trehalose on a laboratory spray-dryer
Eur. J. Pharm. Biopharm.
Enhanced bioavailability of cinnarizine nanosuspensions by particle size engineering: optimization and physicochemical investigations
Mater. Sci. Eng. C
Evaluation of the surface chemistry and drug–polymer interaction of semi-crystalline micro-particles for the development of controlled release formulations
Mater. Sci. Eng. C
Development of nanostructured lipid carriers for the encapsulation and controlled release of vitamin D3
Food Chem.
Preparation and statistical optimization of Losartan Potassium loaded nanoparticles using Box Behnken factorial design: microreactor precipitation
Chem. Eng. Res. Des.
Multiphase microfluidic synthesis of micro-and nanostructures for pharmaceutical applications
Chem. Eng. Sci.
The synthesis of tamoxifen-loaded albumin nanoparticles by homogenizers: optimization and in vitro characterization
J. Drug Deliv. Sci. Technol.
Continuous microchannel precipitation to enhance the solubility of telmisartan with poloxamer 407 using Box–Behnken design approach
J. Drug Deliv. Sci. Technol.
Effects of different combinations of nanocrystallization technologies on avanafil nanoparticles: in vitro, in vivo and stability evaluation
Int. J. Pharm.
On-demand continuous-flow production of pharmaceuticals in a compact, reconfigurable system
Science
Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery
Drug Deliv.
Enhancing the solubility and oral bioavailability of poorly water-soluble drugs using monoolein cubosomes
Chem. Pharm. Bull.
Preparation of concentrated stable fenofibrate suspensions via liquid antisolvent precipitation
Drug Dev. Ind. Pharm.
Engineering docetaxel-loaded micelles for non-small cell lung cancer: a comparative study of microfluidic and bulk nanoparticle preparation
RSC Adv.
Ultrasound-assisted biodiesel production in microreactors
Iran. J. Chem. Eng.
Formulation and process considerations for the design of sildenafil-loaded polymeric microparticles by vibrational spray-drying
Pharm. Dev. Technol.
Optimization of spray-drying process conditions for the production of maximally viable microencapsulated L. acidophilus NCIMB 701748
Dry. Technol.
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Nat. Biotechnol.
A review on micromixers
Micromachines
Soy protein microparticles for enhanced oral ibuprofen delivery: preparation, characterization, and in vitro release evaluation
AAPS PharmSciTech
Encapsulation of yeast (Saccharomyces cereviciae) by spray drying for extension of shelf life
Dry. Technol.
Development considerations for nanocrystal drug products
AAPS J.
Recent advances in engineering microparticles and their nascent utilization in biomedical delivery and diagnostic applications
Lab Chip
A modular microfluidic platform for the synthesis of biopolymeric nanoparticles entrapping organic actives
J. Nanopart. Res.
Controlling particle size of a poorly water-soluble drug using ultrasound and stabilizers in antisolvent precipitation
Ind. Eng. Chem. Res.
Solid lipid nanoparticles for dibucaine sustained release
Pharmaceutics
Liquid anti-solvent recrystallization to enhance dissolution of CRS 74, a new antiretroviral drug
Drug Dev. Ind. Pharm.
Continuous synthesis of drug-loaded nanoparticles using microchannel emulsification and numerical modeling: effect of passive mixing
Int. J. Nanomed.
Control and detection of chemical reactions in microfluidic systems
Nature
Optimization of spray-dried diclofenac sodium-loaded microspheres by screening design
Dry. Technol.
A microreactor-based continuous process for controlled synthesis of poly-methyl-methacrylate-methacrylic acid (PMMA) nanoparticles
J. Mater. Chem. B
Nanoparticle-laden contact lens for controlled ocular delivery of prednisolone: formulation optimization using statistical experimental design
Pharmaceutics
Cited by (89)
Micromixer research trend of active and passive designs
2024, Chemical Engineering ScienceEnhancement of mixing and reaction efficiency of various fluids applications at different microfluidic configuration and design
2024, Chemical Engineering and Processing - Process IntensificationHigh-profile-quality microchannels fabricated by UV picosecond laser for microfluidic mixing
2024, Optics and Laser TechnologyEthoxy acetalated dextran nanoparticles for drug delivery: A comparative study of formulation methods
2023, International Journal of Pharmaceutics: XAn overview on state-of-art of micromixer designs, characteristics and applications
2023, Analytica Chimica Acta